BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 1999
View Archived Issues
EntreMed announces sites for Endostatin phase I clinical trials
Read More
Lynx and Oxagen announce SNP collaboration
Read More
Redox receives Phase II SBIR grant for genital herpes prophylactic
Read More
Noven's transdermal patch for ADHD Rx shows promise in initial clinical study
Read More
Ilex reports progress on Campath development at annual meeting
Read More
Ontogeny and Oxford Asymmetry announce lead optimization collaboration
Read More
Novartis to launch Biomatrix's Synvisc in Mexico and Peru
Read More
Genistein may offer protection against ALS and stroke
Read More
Stockholders approve VIMRx name change
Read More
Ilex initiates clinical testing of vitamin D3 analogue
Read More
Abgenix uses XenoMouse technology to generate new antibody for immunologic diseases
Read More
Chugai reviews progress of selected product candidates at end of fiscal year
Read More
AGI-1067, a new vascular protectant, advances through the development pipeline
Read More
OSI Pharmaceuticals expands Anaderm program with Pfizer
Read More
Zadaxin receives approval in Malaysia for treatment of hepatitis B
Read More
AnorMED initiates phase II clinical trial for HIV therapy
Read More
GW-0072, a novel PPARgamma receptor ligand with unique biological activities
Read More
Study of WR-6026 in HIV-infected patients supports clinical utility in treating PCP
Read More
Fragmin approved in U.S. for treatment of unstable angina and non-Q wave MI
Read More
Menarini's chiral NSAID launched in U.K.
Read More
CPMP recommends expanded approval of Temodal for brain tumor therapy
Read More
Recombinant enzyme plus gene therapy: a unique combination therapy for cancer
Read More
Potent and selective 5-HT1A receptor agonists developed at Pierre Fabre
Read More
Dual antagonists at 5-HT3 and 5-HT4 receptors for GI disorders
Read More
Roche discloses new bicyclic compounds as p38 MAP kinase inhibitors
Read More
Lilly discovers arylpiperazines acting as both 5-HT reuptake inhibitors, 5-HT1D antagonists
Read More
Novel compounds for vitamin D-dependent disorders in development at Roche
Read More
Alpha-aryl-N-alkylnitrones from Centaur useful for neurological, autoimmune, inflammatory disorders
Read More
New, highly selective I1 receptor ligand with blood pressure-lowering effects
Read More
Enol metabolite of tasosartan appears not to contribute to pharmacodynamic effects
Read More
Bosentan may represent new strategy for preventing cardiac and renal complications of hypertension
Read More